ALLEN COOKE: Open Payments
NPI 1851909162 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 48 payments from 19 companies in 2025. Trend: 2023 $1,830 · 2024 $1,507 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $488 |
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Novo Nordisk Inc | 2 | $137 |
| PFIZER INC. | 3 | $71 |
| Corcept Therapeutics | 2 | $50 |
| TOLMAR, INC. | 2 | $39 |
| Exact Sciences Corporation | 2 | $36 |
| Stryker Corporation | 1 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $29 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
Products named: QULIPTA, VRAYLAR, Ozempic, FARXIGA, UBRELVY, Korlym, ELIQUIS, JATENZO.
Industry payments across SC — which companies pay providers there.
